Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Rodman David Malcom sold 2,170 Mineralys Therapeutics, Inc. shares (Form 4)

Traded Apr 9, 2026 · Filed Apr 13, 2026

On Apr 9, 2026, Rodman David Malcom (Chief Medical Officer) sold 2,170 Mineralys Therapeutics, Inc. shares at US$27.38 for US$59,415 under a trading plan, leaving 76,140 shares. Filed Apr 13, 2026 (Form 4).

Sold
2,170 shares
Price
US$27.38
Value
US$59,415
Holding after
76,140 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 9, 2026Common StockOption exercise2,170US$16.0078,310Direct
Apr 9, 2026Common StockSale2,170US$27.3876,140Direct

Source

View original at SEC

Related